Implementation Guidelines - Federal Transit Administration - U.S. ...
Implementation Guidelines - Federal Transit Administration - U.S. ... Implementation Guidelines - Federal Transit Administration - U.S. ...
Page 23 of 100 § 40.85 What drugs do laboratories test for? As a laboratory, you must test for the following five drugs or classes of drugs in a DOT drug test. You must not test “DOT specimens” for any other drugs. (a) Marijuana metabolites. (b) Cocaine metabolites. (c) Amphetamines. (d) Opiate metabolites. (e) Phencyclidine (PCP). § 40.87 What are the cutoff concentrations for initial and confirmation tests? (a) As a laboratory, you must use the cutoff concentrations displayed in the following table for initial and confirmation drug tests. All cutoff concentrations are expressed in nanograms per milliliter (ng/mL). The table follows: Type of Drug or Metabolite Initial Test Confirmation Test (1) Marijuana metabolites 50 (i) Delta-9-tetrahydrocannabinol-9carboxylic acid (THC) (2) Cocaine metabolites (Benzoylecgonine) (3) Phencyclidine (PCP) (4) Amphetamines (i) Amphetamine (ii) Methamphetamine (5) Opiate metabolites (i) Codeine (ii) Morphine (iii) 6acetylmorphine 15 300 150 25 25 1000 2000 500 500 (Specimen must also contain amphetamine at a concentration of greater than or equal to 200 ng/mL 2000 2000 10 Test for 6-AM in the specimen. Conduct this test only when specimen contains morphine at a concentration greater than or equal to 2000 ng/mL. (b) On an initial drug test, you must report a result below the cutoff concentration as negative. If the result is at or above the cutoff concentration, you must conduct a confirmation test. (c) On a confirmation drug test, you must report a result below the cutoff concentration as negative and a result at or above the cutoff concentration as confirmed positive. (d) You must report quantitative values for morphine or codeine at 15,000 ng/mL or above. § 40.89 What is validity testing, and are laboratories required to conduct it? (a) Specimen validity testing is the evaluation of the specimen to determine if it is consistent with normal human urine. The purpose of validity testing is to determine whether certain adulterants or foreign substances were added to the urine, if the urine was diluted, or if the specimen was substituted. (b) As a laboratory, you must conduct validity testing. [65 FR 79526, Dec. 19, 2000, as amended at 66 FR 41951, Aug. 9, 2001; 73 FR 35970, June 25, 2008] § 40.91 What validity tests must laboratories conduct on primary specimens? As a laboratory, when you conduct validity testing under §40.89, you must conduct it in accordance with the requirements of this section. (a) You must determine the creatinine concentration on each primary specimen. You must also determine its specific gravity if you find the creatinine concentration to be less than 20 mg/dL.
Page 24 of 100 (b) You must determine the pH of each primary specimen. (c) You must perform one or more validity tests for oxidizing adulterants on each primary specimen. (d) You must perform additional validity tests on the primary specimen when the following conditions are observed: (1) Abnormal physical characteristics; (2) Reactions or responses characteristic of an adulterant obtained during initial or confirmatory drug tests (e.g., non-recovery of internal standards, unusual response); or (3) Possible unidentified interfering substance or adulterant. (e) If you determine that the specimen is invalid and HHS guidelines direct you to contact the MRO, you must contact the MRO and together decide if testing the primary specimen by another HHS certified laboratory would be useful in being able to report a positive or adulterated test result. [65 FR 79526, Dec. 19, 2000, as amended at 69 FR 64867, Nov.9, 2004] § 40.93 What criteria do laboratories use to establish that a specimen is dilute or substituted? (a) As a laboratory you must consider the primary specimen to be dilute when: (1) The creatinine concentration is greater than or equal to 2mg/dL but less than 20 mg/dL, and (2) The specific gravity is greater than 1.0010 but less than 1.0030 on a single aliquot. (b) As a laboratory you must consider the primary specimen to be substituted when the creatinine concentration is less than 2 mg/dL and the specific gravity is less than or equal to 1.0010 or greater than or equal to 1.0200 on both the initial and confirmatory creatinine tests and on both the initial and confirmatory specific gravity tests on two separate aliquots. [65 FR 79526, Dec. 19, 2000, as amended at 69 FR 64867, Nov.9, 2004] § 40.95 What are the adulterant cutoff concentrations for initial and confirmation tests? (a) As a laboratory, you must use the cutoff concentrations for the initial and confirmation adulterant testing as required by the HHS Mandatory Guidelines and you must use two separate aliquots – one for the initial test and another for the confirmation test. (b) As a laboratory, you must report results at or above the cutoffs (or for pH, at or above or below the values, as appropriate) as adulterated and provide the numerical value that supports the adulterated result. [65 FR 79526, Dec. 19, 2000, as amended at 73 FR 35970, June 25, 2008] § 40.96 What criteria do laboratories use to establish that a specimen is invalid? (a) As a laboratory, you must use the invalid test result criteria for the initial and confirmation testing as required by the HHS Mandatory Guidelines and you must use two separate aliquots – one for the initial test and another for the confirmation test. (b) As a laboratory, for a specimen having an invalid result for one of the reasons outlined in the HHS Mandatory Guidelines, you must contact the MRO to discuss whether sending the specimen to another HHS certified laboratory for testing would be useful in being able to report a positive or adulterated result. (c) As a laboratory, you must report invalid results in accordance with the invalid test result criteria as required by the HHS Guidelines and provide the numerical value that support the invalid result. For pH, report at or above or below the values, as appropriate. (d) As a laboratory, you must report the reason a test result is invalid. [73 FR 35970, June 25, 2008] § 40.97 What do laboratories report and how do they report it? (a) As a laboratory, you must report the results for each primary specimen. The result of a primary specimen will fall into one of the following three categories. However, as a laboratory, you must report the actual results (and not the categories): (1) Category 1: Negative Results. As a laboratory, when you find a specimen to be negative, you must report the test result as being one of the following, as appropriate: (i) Negative, or (ii) Negative-dilute, with numerical values for creatinine and specific gravity. (2) Category 2: Non-negative Results. As a laboratory, when you find a specimen to be non-negative, you must report the test result as being one or more of the following, as appropriate: (i) Positive, with drug(s)/metabolite(s) noted; (ii) Positive-dilute, with drug(s)/ metabolite(s) noted, with numerical values for creatinine and specific gravity; (iii) Adulterated, with adulterant(s) noted, with confirmatory test values (when applicable), and with remarks(s); (iv) Substituted, with confirmatory test values for creatinine and specific gravity; or
- Page 346 and 347: Q: Can a split specimen be sent to
- Page 348 and 349: actual employee of the employer may
- Page 350 and 351: Q: Must collectors, BATs, STTs, MRO
- Page 352 and 353: an observer, or a monitor for co-wo
- Page 354 and 355: Q: If a collector makes an error on
- Page 356 and 357: Appendix H Terms and Definitions
- Page 358 and 359: indirectly, one controls or has the
- Page 360 and 361: Confirmation validity test Confirme
- Page 362 and 363: These terms include any designee of
- Page 364 and 365: Medical Review Officer (MRO) A pers
- Page 366 and 367: Random test Reason to believe Reaso
- Page 368 and 369: Safety-sensitive function Any of th
- Page 370 and 371: trolley bus, or vessel. A “mass t
- Page 373 and 374: 49 CFR Part 40 Updated August 31, 2
- Page 375 and 376: § 40.89 What is validity testing,
- Page 377 and 378: Page 4 of 100 § 40.287 What inform
- Page 379 and 380: Page 6 of 100 Subpart A - Administr
- Page 381 and 382: Page 8 of 100 Medical Review Office
- Page 383 and 384: Page 10 of 100 § 40.17 Is an emplo
- Page 385 and 386: Page 12 of 100 (b) You must request
- Page 387 and 388: Page 14 of 100 (4) The collector's
- Page 389 and 390: Page 16 of 100 (1) To avoid distrac
- Page 391 and 392: Page 18 of 100 (f) Direct the emplo
- Page 393 and 394: Page 20 of 100 (g) As the collector
- Page 395: Page 22 of 100 participate in the D
- Page 399 and 400: Page 26 of 100 (d) If you have not
- Page 401 and 402: Page 28 of 100 December 31 of the p
- Page 403 and 404: Page 30 of 100 (a) Review Copy 2 of
- Page 405 and 406: Page 32 of 100 (1) As the DER, you
- Page 407 and 408: Page 34 of 100 (i) Recent needle tr
- Page 409 and 410: Page 36 of 100 (2) If you receive i
- Page 411 and 412: Page 38 of 100 (iii) If a negative
- Page 413 and 414: Page 40 of 100 (6) Result of the te
- Page 415 and 416: Page 42 of 100 (d) When you receive
- Page 417 and 418: Page 44 of 100 (1) Report that the
- Page 419 and 420: Page 46 of 100 (2) There is not an
- Page 421 and 422: Page 48 of 100 (c) The laboratory r
- Page 423 and 424: Page 50 of 100 (6) The failure to d
- Page 425 and 426: Page 52 of 100 partially meets thes
- Page 427 and 428: Page 54 of 100 (c) As the user of t
- Page 429 and 430: Page 56 of 100 (vi) You must then d
- Page 431 and 432: Page 58 of 100 (i) You may transmit
- Page 433 and 434: Page 60 of 100 (b) In the case of a
- Page 435 and 436: Page 62 of 100 (iii) Key DOT drug t
- Page 437 and 438: Page 64 of 100 § 40.295 May employ
- Page 439 and 440: Page 66 of 100 (e) The requirements
- Page 441 and 442: Page 68 of 100 accident drug test r
- Page 443 and 444: Page 70 of 100 § 40.343 What tasks
- Page 445 and 446: Page 72 of 100 and follow-up testin
Page 24 of 100<br />
(b) You must determine the pH of each primary specimen.<br />
(c) You must perform one or more validity tests for oxidizing adulterants on each primary specimen.<br />
(d) You must perform additional validity tests on the primary specimen when the following conditions are<br />
observed:<br />
(1) Abnormal physical characteristics;<br />
(2) Reactions or responses characteristic of an adulterant obtained during initial or confirmatory drug tests<br />
(e.g., non-recovery of internal standards, unusual response); or<br />
(3) Possible unidentified interfering substance or adulterant.<br />
(e) If you determine that the specimen is invalid and HHS guidelines direct you to contact the MRO, you<br />
must contact the MRO and together decide if testing the primary specimen by another HHS certified laboratory<br />
would be useful in being able to report a positive or adulterated test result.<br />
[65 FR 79526, Dec. 19, 2000, as amended at 69 FR 64867, Nov.9, 2004]<br />
§ 40.93 What criteria do laboratories use to establish that a specimen is dilute or substituted?<br />
(a) As a laboratory you must consider the primary specimen to be dilute when:<br />
(1) The creatinine concentration is greater than or equal to 2mg/dL but less than 20 mg/dL, and<br />
(2) The specific gravity is greater than 1.0010 but less than 1.0030 on a single aliquot.<br />
(b) As a laboratory you must consider the primary specimen to be substituted when the creatinine<br />
concentration is less than 2 mg/dL and the specific gravity is less than or equal to 1.0010 or greater than or equal to<br />
1.0200 on both the initial and confirmatory creatinine tests and on both the initial and confirmatory specific gravity<br />
tests on two separate aliquots.<br />
[65 FR 79526, Dec. 19, 2000, as amended at 69 FR 64867, Nov.9, 2004]<br />
§ 40.95 What are the adulterant cutoff concentrations for initial and confirmation tests?<br />
(a) As a laboratory, you must use the cutoff concentrations for the initial and confirmation adulterant<br />
testing as required by the HHS Mandatory <strong>Guidelines</strong> and you must use two separate aliquots – one for the initial<br />
test and another for the confirmation test.<br />
(b) As a laboratory, you must report results at or above the cutoffs (or for pH, at or above or below the<br />
values, as appropriate) as adulterated and provide the numerical value that supports the adulterated result.<br />
[65 FR 79526, Dec. 19, 2000, as amended at 73 FR 35970, June 25, 2008]<br />
§ 40.96 What criteria do laboratories use to establish that a specimen is invalid?<br />
(a) As a laboratory, you must use the invalid test result criteria for the initial and confirmation testing as<br />
required by the HHS Mandatory <strong>Guidelines</strong> and you must use two separate aliquots – one for the initial test and<br />
another for the confirmation test.<br />
(b) As a laboratory, for a specimen having an invalid result for one of the reasons outlined in the HHS<br />
Mandatory <strong>Guidelines</strong>, you must contact the MRO to discuss whether sending the specimen to another HHS<br />
certified laboratory for testing would be useful in being able to report a positive or adulterated result.<br />
(c) As a laboratory, you must report invalid results in accordance with the invalid test result criteria as<br />
required by the HHS <strong>Guidelines</strong> and provide the numerical value that support the invalid result. For pH, report at or<br />
above or below the values, as appropriate.<br />
(d) As a laboratory, you must report the reason a test result is invalid.<br />
[73 FR 35970, June 25, 2008]<br />
§ 40.97 What do laboratories report and how do they report it?<br />
(a) As a laboratory, you must report the results for each primary specimen. The result of a primary<br />
specimen will fall into one of the following three categories. However, as a laboratory, you must report the actual<br />
results (and not the categories):<br />
(1) Category 1: Negative Results. As a laboratory, when you find a specimen to be negative, you must<br />
report the test result as being one of the following, as appropriate:<br />
(i) Negative, or<br />
(ii) Negative-dilute, with numerical values for creatinine and specific gravity.<br />
(2) Category 2: Non-negative Results. As a laboratory, when you find a specimen to be non-negative, you<br />
must report the test result as being one or more of the following, as appropriate:<br />
(i) Positive, with drug(s)/metabolite(s) noted;<br />
(ii) Positive-dilute, with drug(s)/ metabolite(s) noted, with numerical values for creatinine and specific<br />
gravity;<br />
(iii) Adulterated, with adulterant(s) noted, with confirmatory test values (when applicable), and with<br />
remarks(s);<br />
(iv) Substituted, with confirmatory test values for creatinine and specific gravity; or